Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 17 Source: Estimated
- €3.2 billion turnover
- 300 employees
-
31st Dec 16 Source: Estimated
- €188.1 million turnover
- 500 employees
- 3 more years available »
Ranking
By Turnover
(€3.2 billion)- 29th in Top Companies
- 7th in Health
- 5th in Pharma
By Employees
(300)- 462nd in Top Companies
- 68th in Health
- 47th in Pharma
- 300
- €3.2 billion
Employees
- Julie O'Neill Senior vice president
Latest News
- 2:00pm Amazon serves up US Open in Grand Slam tennis rights foray
- 12:59pm Minister to abstain from Irish bank shareholder votes on bonus plans
- 12:45pm Clinishift founder Aimée Madden wins Bolton Trust / PwC innovation award
- 12:38pm Russia seek compensation over US aluminium sanctions
- 12:09pm Donegal Investment Group reverses financial position